Clinical Trials Browser

OTHER × Cholangiocarcinoma × ceritinib × Clear all

NCT02374489 2018-04-05

A Phase II Trial of LDK378 in ROS1 and /or ALK Over-expressed Advanced Intrahepatic or Hilar Cholangiocarcinoma

Phase 2 Terminated

Gastrointestinal

Cholangiocarcinoma